GlaxoSmithKline, Johnson & Johnson Combination May Control HIV With Monthly Injections

Published: Jul 03, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Monthly injections with HIV therapies from GlaxoSmithKline Plc (GSK) and Johnson & Johnson (JNJ) sustained levels of the drugs in blood that should control the virus, according to a study that suggests the shots may one day provide a safer, more convenient treatment option to daily pills.

Help employers find you! Check out all the jobs and post your resume.

Back to news